Article Details

Salvia Bioelectronics Secures $60M In Series B To Advance Chronic Migraine Implant, Eyes ...

Retrieved on: 2025-05-27 18:48:24

Tags for this article:

Click the tags to see associated articles and topics

Salvia Bioelectronics Secures $60M In Series B To Advance Chronic Migraine Implant, Eyes .... View article details on hiswai:

Excerpt

Medtech Insight spoke with Hubert Martens, CEO of Netherlands-based neuromodulation company Salvia Bioelectronics, about the company's innovative ...

Article found on: medtech.pharmaintelligence.informa.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo